Redcare Pharmacy (DE:RDC)
XETRA:RDC
Want to see DE:RDC full AI Analyst Report?
Total Valuation
Redcare Pharmacy has a market cap or net worth of €987.35M. The enterprise value is €1.23B.
Market Cap€987.35M
Enterprise Value€1.23B
Share Statistics
Redcare Pharmacy has 20,578,390 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding20,578,390
Owned by Insiders2.76%
Owned by Institutions<0.01%
Financial Efficiency
Redcare Pharmacy’s return on equity (ROE) is -0.08 and return on invested capital (ROIC) is -2.11%.
Return on Equity (ROE)-0.08
Return on Assets (ROA)-0.03
Return on Invested Capital (ROIC)-2.11%
Return on Capital Employed (ROCE)-0.03
Revenue Per Employee1.61M
Profits Per Employee-20.63K
Employee Count1,827
Asset Turnover2.36
Inventory Turnover10.97
Valuation Ratios
The current PE Ratio of Redcare Pharmacy is ―. Redcare Pharmacy’s PEG ratio is 1.97.
PE Ratio―
PS Ratio0.45
PB Ratio2.85
Price to Fair Value2.85
Price to FCF-23.25
Price to Operating Cash Flow88.60
PEG Ratio1.97
Income Statement
In the last 12 months, Redcare Pharmacy had revenue of 2.94B and earned -37.70M in profits. Earnings per share was -1.87.
Revenue2.94B
Gross Profit593.70M
Operating Income-23.80M
Pretax Income-47.70M
Net Income-37.70M
EBITDA45.60M
Earnings Per Share (EPS)-1.87
Cash Flow
In the last 12 months, operating cash flow was 10.85M and capital expenditures -100.59M, giving a free cash flow of -89.74M billion.
Operating Cash Flow10.85M
Free Cash Flow-89.74M
Free Cash Flow per Share-4.36
Dividends & Yields
Redcare Pharmacy pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.66
52-Week Price Change-62.90%
50-Day Moving Average42.57
200-Day Moving Average64.49
Relative Strength Index (RSI)54.35
Average Volume (3m)132.76K
Important Dates
Redcare Pharmacy upcoming earnings date is Jul 29, 2026, TBA (Confirmed).
Last Earnings DateMay 6, 2026
Next Earnings DateJul 29, 2026
Ex-Dividend Date―
Financial Position
Redcare Pharmacy as a current ratio of 1.55, with Debt / Equity ratio of 78.81%
Current Ratio1.55
Quick Ratio1.01
Debt to Market Cap0.27
Net Debt to EBITDA7.09
Interest Coverage Ratio-1.17
Taxes
In the past 12 months, Redcare Pharmacy has paid -8.30M in taxes.
Income Tax-8.30M
Effective Tax Rate0.17
Enterprise Valuation
Redcare Pharmacy EV to EBITDA ratio is 35.80, with an EV/FCF ratio of -28.99.
EV to Sales0.56
EV to EBITDA35.80
EV to Free Cash Flow-28.99
EV to Operating Cash Flow70.97
Balance Sheet
Redcare Pharmacy has €135.00M in cash and marketable securities with €354.80M in debt, giving a net cash position of -€219.80M billion.
Cash & Marketable Securities€135.00M
Total Debt€354.80M
Net Cash-€219.80M
Net Cash Per Share-€10.68
Tangible Book Value Per Share€4.26
Margins
Gross margin is 20.57%, with operating margin of -0.81%, and net profit margin of -1.28%.
Gross Margin20.57%
Operating Margin-0.81%
Pretax Margin-1.62%
Net Profit Margin-1.28%
EBITDA Margin1.55%
EBIT Margin-0.81%
Analyst Forecast
The average price target for Redcare Pharmacy is €73.93, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target€73.93
Price Target Upside46.39% Upside
Analyst ConsensusModerate Buy
Analyst Count7
Revenue Growth Forecast21.58%
EPS Growth Forecast22.79%